CV Lattes
ORCID
Abstract
Currently, lymphomas constitute approximately 3% of neoplasms worldwide and are characterized by the abnormal growth of B and T lymphocytes or natural killer (NK) cells. Among aggressive B-cell lymphomas, large B-cell lymphoma (DLBCL) is one of the most biologically and genetically distinct subtypes and, thus, presents heterogeneity in response to standard treatment, which consists of che…